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Ritonavir- and lopinavir-induced eryptosis in a
SARS-CoV-2–infected patient
Gregoire Stalder and Lorenzo Alberio, Centre Hospitalier Universitaire Vaudois
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An 80-year-oldmanwas hospitalized with severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) pneumonia. Because of
worsening clinical and radiological lung involvement, the protease
inhibitors lopinavir/ritonavir were prescribed. Eight days later,
schistocytes appeared on the patient’s blood smear (panel B). His
laboratory results indicated the following: hemoglobin, 7 g/dL;
reticulocytes, 193 103/mL; platelets, 4623 103/mL; and leuko-
cytes, 12.3 3 103/mL. Lactate dehydrogenase was elevated (607
U/L) but all other hemolysis parameters and creatinine were
normal. Blood smear testing (panels A-C: original magnification
31000, hematoxylin and eosin stain) showed marked anisopoi-
kilocytosis (panel B) with echinocytes (q), bite cells (4), kerato-
cytes (⇨), and ghost cells (s). These changes were not present
the day before lopinavir/ritonavir administration (panel A) and
disappeared 5 days after treatment cessation (panel C).
Based on the absence of thrombocytopenia and hemolysis, the
variety of the observed red blood cell (RBC) alterations, and the
timing between their appearance and medication exposure, we
concluded that the RBC morphological alterations were most
likely induced by lopinavir and/or ritonavir. Both have been de-
scribed as agents that induce eryptosis, an RBC-programmed
death that permits clearance of defective and injured erythrocytes
by phagocytosis. Eryptosis is induced by several triggers, such as
oxidative stress, energy depletion, toxins (ie, heavy metals), and
some drugs. It is characterized by increased cytosolic free
calcium concentration and subsequent surface phosphati-
dylserine exposure. Morphological alteration ensues with
volume reduction, membrane vesiculation, and blebbing.
Eventually, altered RBCs are cleared by phagocytosis in the
reticuloendothelial system.
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